Is Gamida Cell Ltd. (GMDA) a Buy, Sell, or Hold?
NASDAQ : GMDA
Gamida Cell Ltd.
$0.0327 USD
$0 (0.0%)
- Volume
- 19.05M
- Average Volume
- 21.71M
- Market Capitalization
- $4.34M
- P/E Ratio
- -0.08
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.04
- Year Low
- $0.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.16
Company Overview
NASDAQ
Abigail L. Jenkins
Biotechnology
Healthcare
GMDA
143
IL
USD
Liquidity Metrics
-28.13
2.16
2.09
1.85
0.00
Sales & Valuation
$1.78M
2.43
-1.65
-0.05
-0.54
Profitability
-$0.57
-$63M
-3531.17%
-3531.17%
1148.30%
-61.65%
P/E Metrics
-0.08
0.00
0.00
Analyst Price Target & Rating
0/5
8 Analysts
%
Financial Health Scores
-12.90
2/9
-$61.34M
$79.56M
$98.29M
-$78.2M
Key Metrics (TTM)
$40.73M
22.83
-0.76
2.16
1148.30%
-86.17%
-1296.62%
-1849.10%
332 days
Company Executives
| Name | Title |
|---|---|
| Joshua F. Patterson | General Counsel & Chief Compliance Officer |
| Ronit Simantov | Chief Medical Officer & Chief Scientific Officer |
| Abigail L. Jenkins | President, Chief Executive Officer & Director |
| Tracey Lodie | Scientific Advisor & Consultant |
| Vladimir Melnikov | Senior Vice President of Global Operations & Manufacturing |
| Linda Stamler | Vice President of Marketing & Account Management |
| Michele Ilene Korfin | Chief Operating & Chief Commercial Officer |
| Penny Bushell | Chief Human Resource Officer |
| Naftali Brikashvili | Senior Vice President Finance & Operations |
| Mary Theresa Coelho | Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer |
Poll Results
No votes yet today — be the first to share your view!
About Gamida Cell Ltd. (NASDAQ:GMDA) Stock
Gamida Cell Ltd. operates as a clinical-stage biopharmaceutical firm, dedicated to pioneering cell therapies aimed at eradicating blood cancers and other severe hematological conditions. The company's leading investigational product, omidubicel—a specialized cell therapy—has successfully concluded its Phase III clinical evaluation for individuals afflicted with high-risk hematologic malignancies. Furthermore, it is currently undergoing Phase I/II trials for patients suffering from severe aplastic anemia. Another significant therapeutic candidate, GDA-201, an immunotherapy harnessing natural killer cells, is progressing through Phase I/II studies to address relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Beyond these, Gamida Cell is actively advancing a broader natural kil ... ler (NK) cell pipeline, which includes GDA-301, GDA-401, GDA-501, and GDA-601, with the ambition of treating both hematologic cancers and solid tumors. Founded in 1998, the company maintains its corporate headquarters in Jerusalem, Israel.
Frequently Asked Questions
-
What is the current Gamida Cell Ltd. (GMDA) stock price?
-
Gamida Cell Ltd.(NASDAQ:GMDA) stock price is $0.0327 in the last trading session. During the trading session, GMDA stock reached the peak price of $0.0395 while $0.0327 was the lowest point it dropped to. The percentage change in GMDA stock occurred in the recent session was 0.0% while the dollar amount for the price change in GMDA stock was $0.
-
GMDA's industry and sector of operation?
-
The NASDAQ listed GMDA is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of GMDA?
-
Joshua F. Patterson | General Counsel & Chief Compliance Officer
Ronit Simantov | Chief Medical Officer & Chief Scientific Officer
Abigail L. Jenkins | President, Chief Executive Officer & Director
Tracey Lodie | Scientific Advisor & Consultant
Vladimir Melnikov | Senior Vice President of Global Operations & Manufacturing -
How many employees does GMDA have?
-
Number of GMDA employees currently stands at 143. GMDA operates from 5 Nahum Heftsadie Street, Jerusalem, None 91340, IL.
-
Link for GMDA official website?
-
Official Website of GMDA is: https://www.gamida-cell.com
-
How do I contact GMDA?
-
GMDA could be contacted at phone #972 2 659 5666 and can also be accessed through its website. GMDA operates from 5 Nahum Heftsadie Street, Jerusalem, None 91340, IL.
-
How many shares of GMDA are traded daily?
-
The average number of GMDA shares traded daily for last 3 months was 21.71M.
-
What is the market cap of GMDA currently?
-
The market value of GMDA currently stands at $4.34M with its latest stock price at $0.0327